



- Stock: In Stock
- Model: 183885
0% Customers recommend this product
-
5 Awesome0%
-
4 Great0%
-
3 Average0%
-
2 Bad0%
-
1 Poor0%
Reviews Over Vinpocetine of the tab. of 5 mg No. 30
- (0)
Total Reviews (0)
click here write review to add review for this product.
Report this review.
Description
tablets "Vinpocetine" are applied in:
- neurology (for treatment of various forms of cerebrovascular pathology: states after the postponed disturbance of cerebral circulation (stroke), vertebrobazilyarny insufficiency, vascular dementia, cerebral atherosclerosis, posttraumatic and hypertensive encephalopathy; promotes reduction of mental and neurologic symptomatology in cerebrovascular pathology);
- ophthalmology (for treatment of chronic vascular pathology of a horioidea (eye choroid) and a retina);
- orthorhinolaryngology (for treatment of senile relative deafness of perceptual type, Menyer's disease and sonitus).
Structure
Active ingredient - vinpocetine (one tablet contains a Vinpocetine 5 mg).
Excipients: lactose, monohydrate; corn starch; talc; magnesium stearate.
Contraindication
Hypersensitivity to active agent or to any of excipients.
Route of administrationto Apply
inside after a meal. The daily dose for adults makes 15-30 mg (3 times a day on 5-10 mg). Duration of treatment is determined by the doctor individually. Feature of use
Pregnant
Use of medicament during pregnancy and feeding by a breast contraindicated.
Children
to Children not to use medicament (due to the lack of clinical data).
Drivers
Are not present data on influence of a Vinpocetine on ability to run motor transport or to work with mechanisms, but it is necessary to be careful, considering emergence probability at use of medicament of drowsiness, dizziness.
Overdose toSymptoms of overdose are unknown to
. According to literary data, the dose of 60 mg/days is safe. Single dose of 360 mg of a Vinpocetine was not followed by development of either cardiovascular, nor other side effects. Side effects
from blood and lymphatic system: leukopenia, thrombocytopenia, anemia, agglutination of erythrocytes.
from the immune system: hypersensitivity.
Disturbance of metabolism and food: hypercholesterolemia, loss of appetite, anorexia, diabetes.
Mental disorders: insomnia, sleep disorders, concern, excitement, euphoria, depression.
from nervous system: headache, dizziness, dysgeusia, stupor, hemiparesis, drowsiness, amnesia, tremor, spasms.
from an organ of sight: papilledema, conjunctiva hyperaemia.
from organs of hearing and a labyrinth: vertigo, hyperacusia, gipoakuziya, sonitus.
from heart: ischemia/myocardial infarction, stenocardia, bradycardia, tachycardia, premature ventricular contraction, heartbeat, arrhythmia, fibrillation of auricles.
from the vascular system: arterial hypotension, arterial hypertension, inflows, thrombophlebitis, fluctuations of arterial blood pressure.
from a digestive tract: discomfort in a stomach, dryness in a mouth, nausea, an abdominal pain, a constipation, diarrhea, dyspepsia, vomiting, a dysphagy, stomatitis.
from skin and hypodermic cellulose: erythema, hyperhidrosis, itching, urticaria, rash, dermatitis.
Storage conditionsto Store
in original packing at a temperature not above 25 °C, out of children's reach.
an expiration date - 4 years.
Specifications
Characteristics | |
Active ingredients | Vinpocetine |
Amount of active ingredient | 5 mg |
Applicant | GNCLS experimental plant |
Code of automatic telephone exchange | N06BX18 Vinpocetine |
Interaction with food | Later |
Light sensitivity | Not sensitive |
Market status | Generic-generic |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | blister |
Producer | HEALTH TOB GNTSLS |
Quantity in packing | 30 tablets (3 blisters on 10 pieces) |
Release form | tablets for internal use |
Route of administration | Oral |
Sign | Domestic |
Storage temperature | from 5 °C to 25 °C |
Trade name | Vinpocetine |